CMS Clarifies CLIA Certification Requirements for Remote Cytology

CMS Clarifies CLIA Certification Requirements for Remote Cytology

The Centers for Medicare & Medicaid Services (CMS) recently clarified Clinical Laboratory Improvement Act (CLIA) certification requirements for remote cytology.

The College of American Pathologists (CAP) requested clarification because of recent federal policy updates, including updates to requirements related to CLIA certification for laboratories. CMS officials explained that remote Rapid Adequacy Assessments (also known as rapid on-site evaluation or ROSE) require a separate CLIA certificate for an off-site location where a review is performed, including virtual slide review. CMS also clarified that adequacy assessment does not count as a separate examination for workload limit purposes.

Source:

https://www.cap.org/advocacy/latest-news-and-practice-data/march-31-2026#story2

American Medical Association and Partner Organizations Call for Stronger Enforcement of No Surprises Act

American Medical Association and Partner Organizations Call for Stronger Enforcement of No Surprises Act

The American Medical Association and 111 specialty societies and state medical associations are urging administration officials to implement strong...

Read More
TELCOR Promotions - May 2026

TELCOR Promotions - May 2026

Lincoln, NE – April 2026 TELCOR is proud to announce the promotion Alexis Determan to Senior Implementation Analyst, RCM and Alyson Lyon to Technical...

Read More
Virginia Takes Legislative Action on Steering Referrals of Laboratory Services

Virginia Takes Legislative Action on Steering Referrals of Laboratory Services

Virginia Gov. Abigail Spanberger signed Senate Bill 745 on April 6, prohibiting health plans from imposing unnecessary restrictions on referrals to...

Read More